Corcept Therapeutics (CORT) Cash from Operations (2010 - 2026)
Corcept Therapeutics (CORT) posted Cash from Operations of 33543000.0 for Q2 2026, up 299.99% sequentially from 16772000.0 in Q1 2026, and down 24.28% YoY from 44297000.0 in Q2 2025.
Corcept Therapeutics (CORT) Cash from Operations (2010 - 2026) Analysis & Trends
Corcept Therapeutics has reported Cash from Operations for 17 years, with the latest figure at 33543000.0 in Q2 2026.
- Quarterly Cash from Operations fell 24.28% year-over-year to 33543000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 109700000.0 (down 39.86% YoY) and the FY2025 annual result came in at 141996000.0, down 28.39% from the prior year.
- Cash from Operations improved to 33543000.0 in Q2 2026 per CORT's latest filing, from 16772000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 73293000.0 in Q3 2024 and troughed at 16772000.0 in Q1 2026.
- A 5-year average of 33559222.22 and a median of 34447500.0 in 2022 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2024 and 2026: Cash from Operations surged 986.24% in 2024, then plunged 451.61% in 2026.
- Over 5 years, Cash from Operations stood at 33388000.0 in 2022, then slumped by 83.44% to 5529000.0 in 2023, then soared by 986.24% to 60058000.0 in 2024, then plunged by 35.98% to 38448000.0 in 2025, then dropped by 12.76% to 33543000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 33543000.0, 16772000.0, and 38448000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn | 33.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.54 Mn |
| Jun 30, 2026 | 33.54 Mn |
| Mar 31, 2026 | -16.77 Mn |
| Mar 31, 2026 | -16.77 Mn |
| Dec 31, 2025 | 38.45 Mn |
| Dec 31, 2025 | 38.45 Mn |
| Sep 30, 2025 | 54.48 Mn |
| Sep 30, 2025 | 54.48 Mn |
| Jun 30, 2025 | 44.30 Mn |
| Jun 30, 2025 | 44.30 Mn |
| Mar 31, 2025 | 4.77 Mn |
| Mar 31, 2025 | 4.77 Mn |
| Dec 31, 2024 | 60.06 Mn |
| Dec 31, 2024 | 60.06 Mn |
| Sep 30, 2024 | 73.29 Mn |
| Sep 30, 2024 | 73.29 Mn |
| Jun 30, 2024 | 41.19 Mn |
| Jun 30, 2024 | 41.19 Mn |
| Mar 31, 2024 | 23.76 Mn |
| Mar 31, 2024 | 23.76 Mn |